Infection and Immunity, February 2001, p. 706-711, Vol. 69, No. 2
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.2.706-711.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Departments of Veterinary Microbiology and Preventive Medicine1 and Veterinary Pathology,2 Veterinary Medical Research Institute, Iowa State University, Ames, Iowa 50011, and Zoonotic Diseases Research Unit, National Animal Disease Center, Agricultural Research Service, U.S. Department of Agriculture, Ames, Iowa 500103
Received 8 August 2000/Returned for modification 21 September 2000/Accepted 23 October 2000
| |
ABSTRACT |
|---|
|
|
|---|
Brachyspira (Serpulina)
hyodysenteriae induces a mucohemorrhagic diarrheal disease
in pigs. The production of a beta-hemolysin has been considered a major
virulence attribute of this organism. Previous reports have failed to
correlate a specific cloned gene sequence with a purified
beta-hemolytic protein sequence. Thus, questions still remain
concerning the structural gene sequence of the hemolysin. To answer
this question unequivocally, the beta-hemolytic toxin was purified from
extracts of log-phase spirochetes, and the N-terminal amino acid
sequence was determined (K-D-V-V-A-N-Q-L-N-I-S-D-K) and compared with
the translated sequences of previously cloned genes, tlyA
to tlyC. The lack of homology between tlyA to
tlyC translated sequences and the purified beta-hemolytic
toxin sequence resulted in the study that is reported here. A
degenerate probe was designed based on the N-terminal amino acid
sequence of the purified beta-hemolysin and used to screen a B. hyodysenteriae genomic library. Three overlapping clones were
identified, and one was sequenced to reveal an open reading frame
coding for a putative 8.93-kDa polypeptide containing the N-terminal
sequence of the purified beta-hemolysin. To distinguish this gene from the tlyA to tlyC genes, it has been designated
hlyA. A hemolysis-negative Escherichia coli
strains containing hlyA was beta-hemolytic on blood agar
media. Also, the hemolytic activity of the recombinant protein had
identical protease and lipase sensitivities and electrophoretic mobility to those of native B. hyodysenteriae
beta-hemolysin. Based on sequence analysis, the translated protein had
a pI of 4.3, an
-helical structure, and a phosphopantetheine binding motif. Hybridization analysis of genomic DNA indicated that the hlyA gene was present in B. hyodysenteriae and
B. intermedia but was not detected in B. innocens, B. pilosicoli, or B. murdochii under high-stringency conditions. The location of hlyA on
the chromosomal map was distinct from the locations of
tlyA, tlyB, and tlyC.
| |
INTRODUCTION |
|---|
|
|
|---|
Brachyspira (Serpulina) hyodysenteriae, the etiologic agent of swine dysentery, induces a mucohemorrhagic diarrheal disease in susceptible pigs and a severe cecitis in mice (7, 11). Virulence attributes associated with B. hyodysenteriae include the production of a beta-hemolysin, the presence of a biologically active lipooligosaccharide, motility, and the presence of an NADH oxidase (5, 12, 19, 20, 22, 23). Beta-hemolytic activity has been one of the major phenotypic characteristics used to distinguish B. hyodysenteriae from avirulent species of Brachyspira. Numerous methods have been reported for hemolysin production and purification, most involving traditional protein purification techniques (13-15, 23). These studies have been at variance in their reports of the apparent molecular mass of the isolated hemolytic factor, ranging from 19 to 74 kDa. The beta-hemolysin has been shown to be physicochemically similar to streptolysin S; it is oxygen stable, heat labile, and active over a wide pH range, requires an appropriate carrier for its isolation (usually RNA-core), and is sensitive to both protease and lipase digestion (14, 23).
The biologic activity of the beta-hemolysin recovered from B. hyodysenteriae has been studied primarily in vitro. Early work indicated that the binding of the hemolysin to erythrocytes was temperature independent while lytic activity required physiologic temperatures and that erythrocyte swelling occurred prior to lysis (22). While proteolytic or phospholipase-like activity has not been associated with the beta-hemolysin of B. hyodysenteriae, hemoglobin release was detected prior to cell swelling, indicating a cytolytic mechanism involving membrane perturbation and leakage (22, 23). Studies with osmoprotectants indicated that a pore with a diameter of 1.0 to 1.1 nm was formed by the beta-hemolysin (10). Additional studies from this laboratory have indicated that purified beta-hemolysin affects the integrity of epithelial cell monolayers and induces colonic epithelial cell damage similar to that caused by infection with B. hyodysenteriae (9, 26).
Previously, three separate genes from B. hyodysenteriae have been identified and associated with beta-hemolysis based on their ability to induce a hemolytic phenotype in Escherichia coli (7, 11). These three genes, referred to as tlyA, tlyB, and tlyC, encode gene products with apparent molecular masses of 26.9, 93.3, and 30.8 kDa, respectively. Furthermore, it was demonstrated that tlyA was detected in the pathogenic B. hyodysenteriae but not the nonpathogenic B. innocens. The tlyB gene product was reported to have homology to Clp proteins, a class of intracellular proteins that display proteolytic activities as well as being regulators of proteolysis. None of these three genes, however, have been linked directly by protein sequencing to a B. hyodysenteriae-specific gene product that displays hemolytic activity or to the native beta-hemolysin. Likewise, none of the recombinant products synthesized from the cloned genes have been shown to possess the biochemical properties attributed to the B. hyodysenteriae beta-hemolysin (13, 14, 22, 23), with the possible exception that E. coli harboring tly containing plasmids have hemolytic activity (18, 25). Recent studies identifying the cryptic E. coli hemolysin SheA (3) raise the possibility that tlyA, tlyB, and tlyC code for proteins that induce SheA or other cryptic E. coli hemolysins. In fact, in an earlier study, a cloned Salmonella gene, slyA, was originally thought to be a hemolysin gene (16) but was later identified as a transcriptional regulator that activated the expression of sheA in E. coli K-12 (3, 17, 21).
To correlate the beta-hemolysin protein sequence with one of the tly genes, the native protein was purified and the N-terminal amino acid sequence was obtained. Unexpectedly, this sequence was not present in any of the three translated tly genes identified previously. Further studies resulted in the cloning of the gene, hlyA, that encoded the purified beta-hemolysin (i.e., HlyA), and these studies revealed a DNA sequence with no homology to tlyA, tlyB, or tlyC. The coding sequence of hlyA is much smaller than those of the previously reported tly genes, and this is directly correlated with the biochemical analyses of the native beta-hemolysin.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacteria.
B. hyodysenteriae strain B204, serotype 2, was grown as previously described (5). Spirochetes were
grown in 3-liter volumes to a concentration of approximately
109 organisms per ml as determined with a Petroff-Hauser
bacterial counting chamber. Active motility of greater than 75% of the
organisms was desired and interpreted as an indication of a culture
within the log phase of growth. E. coli strains were
routinely grown in Luria-Bertani (LB) broth or on LB agar medium. Phage
plates for LE392 (6) consisted of standard LB agar base
supplemented with 2.5 mM CaCl2 with LB soft agar overlays.
E. coli SOLR [e14-(mcrA)
(mcrCB-hsdSMR-mrr)171 sbcC recB recJ
uvrC umuC::Tn5(Kanr) lac
gyrA96 relA1 thi-1 endA1
R [F' proAB
laclq Z
M15] Su
] was the
Lambda ZAP II recipient for plasmid excision (Stratagene, La Jolla,
Calif.). E. coli BL21(
DE3) is a
DE3 lysogen which carries T7 RNA polymerase under lac promoter control.
Hemolysin preparation and purification.
Crude hemolysin was
prepared by a modification of a method described previously
(13). A 3-liter volume of B. hyodysenteriae culture was centrifuged at 10,000 × g at 4°C for 20 min. Bacteria were suspended in beta-hemolysin extraction buffer
(phosphate-buffered saline [140 mM NaCl, 8 mM
Na2HPO4, 1.5 mM KH2PO4,
2.7 mM KCl; pH 7.2], 0.05% RNA-core [Sigma Chemical Co., St. Louis,
Mo.], 1 mM glucose, 1 mM MgSO4) at 1/20 of the original
culture volume and held at 37°C for 30 min with sufficient agitation
to maintain suspension. Cells were pelleted by centrifugation, the
supernatant was retained and frozen, and the extraction was repeated
three to five times depending on the extent of cell vigor as assessed by observing motility. Supernatants were pooled, vacuum filtered through a 0.22-µm-pore-size filter (Gelman Sciences, Ann Arbor, Mich.), and stored at
70°C until further purification. Throughout all manipulations, beta-hemolysin-containing solutions were maintained at 4°C or less and assayed periodically for hemolytic activity. The
beta-hemolysin-containing supernatant was reduced in volume and
desalted by repeated concentration and reconstitution with sterile
deionized water, utilizing a forced-flow ultrafiltration device with an
approximate molecular mass cutoff filter of 3 kDa (Filtron
Technologies, Northborough, Mass.). This concentrated, crude hemolysin
was loaded onto preparative, nondenaturing 12% polyacrylamide slab
gels and electrophoresed until the dye front reached the bottom of the
gel. The portion of the gel that contained the hemolytic activity was
identified by placing a 2-mm-wide slice (top-to-bottom) of the gel onto
blood agar and incubating it at 37°C for 20 min. The polyacrylamide
gel was then sliced (side-to-side, 3 to 5 mm wide) to excise the
portion of the gel containing the hemolytic activity. The hemolysin was
electroeluted from the acrylamide slices into Tris-glycine buffer (37.6 mM Tris-HCl, 50 mM glycine [pH 7.5]). The supernatant was then
reduced in volume and desalted by ultrafiltration, as described above.
The process was repeated, so that beta-hemolysin preparations were
electrophoresed and electroeluted twice. Preparations were analyzed by
size exclusion capillary electrophoresis, and the N-terminal amino acid
sequence analysis was determined by the Edman reaction. The amino acid
sequence was then used to construct a degenerate oligonucleotide probe for subsequent hybridization and gene identification. The protease and
lipase sensitivity of hemolytic preparations was assessed as previously
described (23).
Library construction and screening. The B. hyodysenteriae genomic library was constructed in Lambda ZAP II using 5- to 10-kb randomly sheared DNA fragments whose ends were polished by DNA polymerase. EcoRI linkers were added using DNA ligase, and the fragments were cloned into Lambda ZAP II EcoRI-digested, dephosphorylated DNA. Following packaging, the library was amplified using standard techniques (24).
To screen the library, the phage were grown at a density of 500 plaques per 85-mm-diameter petri dish. Nitrocellulose disks were used to lift the plaques, and the DNA was denatured with 0.1 M NaOH and baked at 80°C. The lifts were hybridized under standard conditions (24) overnight at 47°C. Positive plaques were purified by standard techniques and rescreened by the above method.DNA manipulations. Plasmids containing cloned B. hyodysenteriae chromosomal DNA fragments were excised in vitro from the corresponding recombinant Lambda ZAP II plaques with helper phage R408 and introduced into E. coli SOLR as specified by the manufacturer (Stratagene). Restriction maps of each cloned fragment were constructed by standard techniques.
DNA sequencing and analysis. Prior to DNA sequence analysis, the region of the three recombinant clones reactive with the degenerate oligonucleotide probe was first determined. This was accomplished by DNA-DNA hybridization using plasmid DNAs digested with EcoRI-EcoRV-HindIII or with ClaI-HindIII. Following separation of the fragments by agarose gel electrophoresis, blotting to a nylon membrane, and hybridization with the degenerate oligonucleotide probe, the region containing the amino-terminal portion of the hemolysin was identified and the sequence of this region was determined in plasmid pISM1236 (see Fig. 2). The reverse primer (5'-CAGGAAACAGCTATGACC-3') and two custom primers designated TV2 (5'-CAAAATAATAGTCGCCCTCAAC-3') and TV7 (5'-TAGCTGTTGACGGCGGAATG-3') were used to obtain complete overlapping sequence. The DNA sequence data were assembled and analyzed for open reading frames and sequence homologies using MacVector software, version 5.0.2. The sequence was also analyzed for sequence motifs using PROSITE software (http://www.genome.ad.jp/SIT/MOTIF.html) (1).
Chromosomal mapping. Restriction endonuclease digestion, pulsed-field gel electrophoresis, and Southern blot analysis of DNA prepared in agarose beads were done as described previously (27). The blots were hybridized and washed at 60°C.
DNA hybridization.
Hybridization was performed to determine
if other Brachyspira species contained homologs of the
beta-hemolysin gene identified in this study in B. hyodysenteriae. Genomic DNAs of six different serpulinal species,
B. innocens strain B256, an unnamed pathogenic chicken
isolate, strain C-1 (proposed name, B. alvinipulli),
B. intermedia strain PWS/A (an isolate from a pig with
nondysenteric colitis), B. murdochii strain 155-20 (a
nonpathogenic isolate from a pig), B. pilosicoli strain
P43/678 (an end-on-attaching spirochete isolated from a pig with
colitis), and B. hyodysenteriae strain B204, were obtained
from Neil Jensen (National Animal Disease Center, Ames, Iowa). All of
the strains analyzed, except for the strongly beta-hemolytic B. hyodysenteriae B204, are moderately to weakly beta-hemolytic. DNA
from each of these spirochetal species was digested individually with
four different restriction enzymes: MboI,
HindIII, AseI, and SspI. Portions
(2 µg) of DNA from each reaction mixture were electrophoresed through
1% agarose gels and blotted to nylon membranes (Hybond-N; Amersham,
Arlington Heights, Ill.). DNA was fixed to nylon membranes by UV
cross-linking using a Stratagene 1800 UV cross-linker. A
ClaI-EcoRI 0.95-kb fragment from plasmid pISM1236
(see Fig. 1) containing the entire open reading frame of the
beta-hemolysin gene was used in these hybridization studies. This
fragment was isolated by agarose gel electrophoresis following plasmid
digestion and was purified using a Qiagen (Chatsworth, Calif.) column.
The probe was labeled with 32P by random-primer labeling
using the Klenow fragment of DNA polymerase (Amersham). The membrane
blots were hybridized overnight and washed twice at 65°C.
Autoradiographs were exposed for 9 h at
80°C.
Nucleotide sequence accession number. The nucleotide sequence of the B. hyodysenteriae hlyA gene has been assigned GenBank accession number U94886.
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
Hemolysin purification and amino acid sequencing.
For the
purposes of biological and biochemical characterization, the crude
preparations of beta-hemolysin obtained from B. hyodysenteriae B204 cells (13) were purified by
ultrafiltration concentration followed by two successive separations on
native polyacrylamide gels and electroelution. Hemolytic activity of the purified fractions was maintained throughout the purification process (Table 1). Analysis of the final
hemolytically active fraction by size exclusion capillary
electrophoresis revealed a single polypeptide peak at 214 nm with an
apparent molecular mass between 19 and 21 kDa (Fig.
1). This was consistent with the results
of Kent et al. (13), suggesting that this gene product was
smaller than the tlyA to tlyC gene products. The
purified hemolysin was then analyzed for its N-terminal amino acid
sequence. The results indicated that a single polypeptide had been
obtained with an N-terminal sequence of K-D-V-V-A-N-Q-L-N-I-S-D-K. No
similar sequences are present in the predicted products of
tlyA to tlyC (25). Thus, a different
gene product was responsible for beta-hemolytic activity of B. hyodysenteriae.
|
|
Cloning of the B. hyodysenteriae hemolysin gene.
To identify the specific gene encoding the beta-hemolysin, a degenerate
oligonucleotide probe
[5'-AAAGATGT(A/T)GT(A/T)GC(A/T)AATCA-3'] was designed
from the N-terminal sequence of the purified beta-hemolysin for
screening the genomic library. When tested by DNA hybridization, the
probe recognized a single HindIII chromosomal fragment
(data not shown). Screening of the B. hyodysenteriae genomic
library resulted in eight positive plaques representing three
independent clones. Following excision of the DNA into pBluescript
plasmids, the three cloned fragments were restriction mapped (Fig.
2). The three plasmids were designated
pISM1235 to pISM1237. Each of the cloned fragments contained a
ClaI-HindIII fragment of approximately 0.45 kb, which reacted positively with the degenerate probe (data not
shown). Colonies of the E. coli host strain SOLR were
converted from a nonhemolytic to a hemolytic phenotype when carrying
these plasmids (Fig. 3). Control strains
containing either pBluescript SK(
) (Stratagene) or a pBluescript
SK(
) derivative with an unrelated 4-kb insert of B. hyodysenteriae chromosomal DNA were hemolytically negative on
blood agar. They were also negative by DNA hybridization when probed
with the degenerate oligonucleotide (data not shown).
|
|
|
Sequence analysis of hlyA.
The hlyA predicted
gene product had a molecular mass of 8.93 kDa, and it appeared to
contain an unusual 7-amino-acid signal sequence that was cleaved from
the mature secreted protein as determined by protein sequencing (Fig.
4). The translated product had a pI of 4.3 and a predicted rod-shaped
or linear conformation arising from an
-helical structure (data not
shown). The linear nature of the hlyA gene product may
explain the disagreement between the predicted molecular mass and that
estimated by size exclusion capillary electrophoresis in this study (19 to 21 kDa); i.e., linear proteins tend to appear larger than globular
proteins of similar size by size exclusion chromatography.
Discrepancies in the previously reported molecular masses of the
beta-hemolysin of B. hyodysenteriae may also be attributable
to the predicted rod shape of this molecule (13), or,
depending on the ionic strength of the buffer and the protein
concentration, multimeric forms of the protein could also explain these
differences. The translation product contained a conserved
phosphopantetheine binding site (amino acid residues 32 through 47),
suggesting that there is posttranslational modification of the
beta-hemolysin (Fig. 4). Posttranslational modification (e.g., fatty
acid binding) would also be consistent with the loss of hemolytic
activity following lipase treatment (data not shown). It is not known
if hlyA is part of an operon or is expressed independently
of nearby genes.
DNA hybridization analysis.
hlyA was localized on the
3.2-Mbp physical and genetic map of B. hyodysenteriae B78T
by Southern blot hybridization. This gene is located on the
EclA, SalA, and SmaB fragments
(27), thus placing it in a region poorly defined by mapped
restriction sites. Figure 5 shows the
region of the chromosome represented by these fragments. The
nox gene, which encodes NADH oxidase, is found in the same
region of the genome. hlyA is not adjacent to
tlyA, tlyB, or tlyC, three other genes
reported to encode hemolytic activity in recombinant E. coli
(25).
|
|
Analysis of recombinant HlyA protein. E. coli strains containing plasmids pISM1235 to pISM1237 were hemolytic on blood agar (Fig. 3). HlyA does not appear to be readily released from recombinant E. coli, however, because the appearance of hemolytic colonies occurred only after 48 h of incubation, presumably as cells died. In comparison to the release of the native hemolysin from B. hyodysenteriae, it was necessary to treat recombinant E. coli with lysozyme, EDTA, and sonication to obtain sufficient quantities of the hemolysin for analysis (data not shown). The inability of recombinant E. coli strains to efficiently secrete the beta-hemolysin may relate to the unusual N-terminal sequence of HlyA, which is not present in the mature protein but is present in the coding sequence. It is likely that this 7-amino-acid sequence at the N-terminal end of HlyA serves as a signal sequence in B. hyodysenteriae but does not facilitate secretion by E. coli. By contrast, the native beta-hemolysin was recovered in supernatant fluid following incubation of log-phase B. hyodysenteriae in extraction buffer and removal of the bacterial cells by centrifugation. There was no enzymatic or mechanical disruption of the spirochetes required to obtain the hemolysin, suggesting that the activity was secreted or released from viable cells. The native and recombinant hemolysin shared additional physicochemical characteristics in that both were resistant to inactivation by trypsin digestion but were inactivated by nonspecific protease or lipase treatment as previously described (23). In combination, these data and observations suggest that the hemolytic activity of the recombinant E. coli was the direct result of the hlyA gene expression and not the induction of a cryptic hemolysin from the host E. coli strain.
Relationship of hlyA to tlyA, tlyB, and tlyC. Previous investigators have reported the cloning and sequencing of three putative hemolysin genes from B. hyodysenteriae (18, 25). Identification of these genes depended solely on induction of a hemolytic phenotype in E. coli. Given the recent report of a cryptic hemolysin in E. coli K-12 (i.e., the sheA product) controlled by DNA binding proteins (3), questions should be raised regarding the nature of the tly Brachyspira gene products. The tlyA to tlyC gene products could represent regulatory proteins that upregulate sheA or other unknown cryptic hemolysins in E. coli. For instance, tlyB has homology to ClpB, a class of regulatory proteins and proteases. In addition, there has not been a report of a direct link between the purified recombinant hemolytic activity from tly-containing clones and a specific protein in B. hyodysenteriae. In contrast, our studies correlate N-terminal amino acid sequence from purified, active beta-hemolysin with the cloned gene DNA sequence. Additionally, hlyA does not map near the tly genes (Fig. 5), nor does it reside within the lysogenic phage of B. hyodysenteriae (T. B. Stanton, personal communication). Whether the previously described tly genes (18, 25) code for other hemolysins or serve as regulatory proteins in B. hyodysenteriae can be answered only by more defined biochemical and genetic studies. The biologic activity of purified HlyA, however, has been shown to induce murine colonic lesions similar to those caused by B. hyodysenteriae and to disrupt the integrity of epithelial cell monolayers (9, 26).
In summary, a beta-hemolysin was purified from B. hyodysenteriae and an unambiguous N-terminal amino acid sequence was obtained. Construction of an oligonucleotide probe from that amino acid sequence facilitated identification, cloning, and sequencing of the gene, hlyA, encoding the protein. Analysis of that sequence provided information about the physicochemical properties of the hlyA gene product. There was no relationship between hlyA and three previously identified B. hyodysenteriae genes (i.e., tlyA to tlyC), suggesting that hlyA was unique. Based on sequence analysis, the hlyA gene and gene product did have homology to plant and bacterial acyl carrier proteins. DNA-DNA hybridization performed on six different species of Brachyspira indicated that at least one other species, B. intermedia, possessed the hlyA gene. This study provides the first direct linkage between a purified hemolytic protein from B. hyodysenteriae and its cognate gene sequence.| |
ACKNOWLEDGMENTS |
|---|
We acknowledge Thad Stanton, National Animal Disease Center, USDA, Ames, Iowa, for supplying the Lambda ZAP II library and oligonucleotide and for useful discussions on cloning of the hemolysin gene. We also thank Mary Jo Schmerr, National Animal Disease Center, for helpful discussions on protein purification and for assistance in capillary electrophoresis. We also thank Tina VanDyk and Jill Randolph for technical assistance.
D.L.H. was supported by USDA National Needs Graduate Fellowship 88-38420-3832. This work was supported by funds from USDA CSRS, section 1433.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Veterinary Medical Research Institute, Iowa State University, 1802 Elwood Dr., Ames, IA 50011. Phone: (515) 294-3270. Fax: (515) 294-1401. E-mail: mjwannem{at}iastate.edu.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Bairoch, A.
1992.
PROSITE a dictionary of sites and patterns in proteins.
Nucleic Acids Res.
20:2013-2018.
|
| 2. | Binek, M., and Z. M. Szynkiewicz. 1984. Physiological properties and classification of strains of Treponema sp. isolated from pigs in Poland. Comp. Immunol. Microbiol. Infect. Dis. 7:141-148[CrossRef][Medline]. |
| 3. | del Castillo, F. J., S. C. Leal, F. Moreno, and I. del Castillo. 1997. The Escherichia coli K-12 sheA gene encodes a 34-kDa secreted haemolysin. Mol. Microbiol. 25:107-115[CrossRef][Medline]. |
| 4. | Fellstrom, C., and A. Gunnarsson. 1995. Phenotypic characterisation of intestinal spirochaetes isolated from pigs. Res. Vet. Sci. 59:1-4[CrossRef][Medline]. |
| 5. |
Greer, J. M., and M. J. Wannemuehler.
1989.
Comparison of the biological responses induced by lipopolysaccharide and endotoxin of Treponema hyodysenteriae and Treponema innocens.
Infect. Immun.
57:717-723 |
| 6. | Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:557-580[Medline]. |
| 7. | Harris, D. L., R. D. Glock, C. R. Christensen, and J. M. Kinyon. 1972. Innoculation of pigs with Treponema hyodysenteriae (new species) and reproduction of the disease. Vet. Med. Small Anim. Clin. 67:61-64[Medline]. |
| 8. | Hudson, M. J., T. J. Alexander, and R. J. Lysons. 1976. Diagnosis of swine dysentery: spirochaetes which may be confused with Treponema hyodysenteriae. Vet. Rec. 99:498-500[Abstract]. |
| 9. | Hutto, D. L., and M. J. Wannemuehler. 1999. A morphologic comparison of the effects of Serpulina hyodysenteriae or its native hemolysin on murine cecal mucosa. Vet. Pathol. 36:412-422[Abstract]. |
| 10. | Hyatt, D. R., S. Muir, and L. A. Joens. 1992. Biophysical characteristics of the Serpulina hyodysenteriae native hemolysin, p. 15. In Conference for Research Workers in Animal Diseases. |
| 11. |
Joens, L. A., and R. D. Glock.
1979.
Experimental infection in mice with Treponema hyodysenteriae.
Infect. Immun.
25:757-760 |
| 12. | Kennedy, M. J., D. K. Rosnick, R. G. Ulrich, and R. J. Yancey. 1988. Association of Treponema hyodysenteriae with porcine intestinal mucosa. J. Gen. Microbiol. 134:1565-1576[Medline]. |
| 13. | Kent, K. A., R. M. Lemcke, and R. J. Lysons. 1988. Production, purification and molecular weight determinations of the haemolysin of Treponema hyodysenteriae. J. Med. Microbiol. 27:215-224[Abstract]. |
| 14. |
Knoop, F. C.
1981.
Investigation of a hemolysin produced by enteropathogenic Treponema hyodysenteriae.
Infect. Immun.
31:193-198 |
| 15. | Lemcke, R. M., and M. R. Burrows. 1982. Studies on a haemolysin produced by Treponema hyodysenteriae. J. Med. Microbiol. 15:205-214[Medline]. |
| 16. |
Libby, S. J.,
W. Goebel,
A. Ludwig,
N. Buchmeier,
F. Bowe,
F. C. Fang,
D. G. Guiney,
J. G. Songer, and F. Heffron.
1994.
A cytolysin encoded by Salmonella is required for survival within macrophages.
Proc. Natl. Acad. Sci. USA
91:489-493 |
| 17. | Ludwig, A., C. Tengel, S. Bauer, A. Bubert, R. Benz, H. J. Mollenkopf, and W. Goebel. 1995. SlyA, a regulatory protein from Salmonella typhimurium, induces a haemolytic and pore-forming protein in Escherichia coli. Mol. Gen. Genet. 249:474-486[CrossRef][Medline]. |
| 18. |
Muir, S.,
M. B. H. Koopman,
S. J. Libby,
L. A. Joens,
F. Heffron, and J. G. Kusters.
1992.
Cloning and expression of a Serpula (Treponema) hyodysenteriae hemolysin gene.
Infect. Immun.
60:529-535 |
| 19. |
Nuessen, M. E.,
J. R. Birmingham, and L. A. Joens.
1982.
Biological activity of a lipopolysaccharide in the pathogenicity of Treponema hyodysenteriae.
Infect. Immun.
37:138-142 |
| 20. | Nuessen, M. E., L. A. Joens, and R. D. Glock. 1983. Involvement of lipopolysaccharide in the pathogenicity of Treponema hyodysenteriae. J. Immunol. 131:997-999[Abstract]. |
| 21. | Oscarsson, J., Y. Mizunoe, B. E. Uhlin, and D. J. Haydon. 1996. Induction of haemolytic activity in Escherichia coli. Mol. Microbiol. 20:191-199[Medline]. |
| 22. | Saheb, S. A., and L. Lafleur. 1980. Characteristics of the interaction of a treponemal hemolysin with rabbit erythrocytes. Biochimie 62:787-793[Medline]. |
| 23. | Saheb, S. A., L. Massicotte, and B. Picard. 1980. Purification and characterization of Treponema hyodysenteriae hemolysin. Biochimie 62:779-785[Medline]. |
| 24. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 25. | ter Huurne, A. A. H. M., S. Muir, M. Vanhouten, B. A. M. Vanderzeijst, W. Gaastra, and J. G. Kusters. 1994. Characterization of three putative Serpulina hyodysenteriae hemolysins. Microb. Pathog. 16:269-282[CrossRef][Medline]. |
| 26. |
Wannemuehler, M. J.,
D. Akili,
D. Hutto,
K. Harkins,
M. Crump, and M. J. Schmerr.
1994.
The pathgenic potential of a -hemolysin from Serpulina hyodysenteriae.
J. Cell. Biochem. Suppl.
18A:63.
|
| 27. |
Zuerner, R. L., and T. B. Stanton.
1994.
Physical and genetic map of the Serpulina hyodysenteriae B78(T) chromosome.
J. Bacteriol.
176:1087-1092 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|